Records containing: Idiopathic Pulmonary Fibrosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-02-15Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2016-01-05A Multicenter, Open-Label, Phase II Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations
-
CLINICAL_TRIALS study record update · 2015-12-29A Phase I Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2015-12-03Phase II Trial of Zileuton Compared to Azathioprine/Prednisone for the Treatment of Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2015-12-02The Role of Microaspiration in Idiopathic Pulmonary Fibrosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-11-30Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2015-10-27Reliability of the 4 Metre Gait Speed in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2015-09-03Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2015-07-13A Treatment Protocol to Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone
-
CLINICAL_TRIALS study record update · 2015-07-09A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-6624 in Adult Subjects With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2015-06-30Default Options in Advance Directives for Veterans With Serious Illnesses: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2015-04-21Determinants of Outcome in Diffuse Parenchymal Lung Disease
-
CLINICAL_TRIALS study record update · 2015-04-13Phase I, Open-Label, Multi-Center, Single-Dose, Dose-Escalating, Safety, Tolerability and Pharmacokinetic of GC1008 in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2015-04-10Conducting Airways in Lung Fibrosis
-
CLINICAL_TRIALS study record update · 2015-04-09The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease
-
CLINICAL_TRIALS study record update · 2015-03-12A Randomized, Double-Blind, Placebo Controlled, Phase 3 Study of the Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (ASCEND Trial)
-
CLINICAL_TRIALS study record update · 2015-01-27Employment of 68Ga-DOTA-NOC in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2015-01-16Rehabilitation of IPF Patients: Effects of Exercise and Oxidant Stress
-
CLINICAL_TRIALS study record update · 2015-01-06A Double-blind, Randomised, Placebo-controlled (Within a Dose Group) Study to Evaluate Safety and Pharmacokinetics of Multiple Rising Doses of BIBF 1120 at 50 mg Bid (14 Days), 100 mg Bid (14 Days), and 150 mg Bid (28 Days) p.o., on Top of Standard Medical Care With Stratification According to Pirfenidone Use, in Japanese Patients With Idiopathic Pulmonary Fibrosis.
-
CLINICAL_TRIALS study record update · 2014-11-05A Study of the Pharmacokinetics and Deposition of Inhaled Salbutamol in Patients With Idiopathic Pulmonary Fibrosis (TOPICAL-IPF)
-
CLINICAL_TRIALS study record update · 2014-11-03A Randomized, Double-Masked, Sponsor-Unmasked, Ascending Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PRM-151 Administered Intravenously to Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2014-05-13A Prospective, Multicentric, Phase I/II, Open Label, Randomized, Interventional Study to Evaluate the Safety and Efficacy of Intravenous Autologous Adipose Derived Adult Stem Cells for Treatment of Idiopathic Pulmonary Fibrosis (IPF).
-
CLINICAL_TRIALS study record update · 2014-05-13A Multicenter, Randomized, Double-blind, Placebo-controlled Trial for Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2014-04-22A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Evaluate the Efficacy and Safety of Ambrisentan in Subjects With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
-
CLINICAL_TRIALS study record update · 2014-04-08ARTEMIS-IPF: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group, Event Driven Study to Evaluate the Efficacy and Safety of Ambrisentan in Subjects With Early Idiopathic Pulmonary Fibrosis (IPF)